Commit To Purchase Merrimack Pharmaceuticals At $7, Earn 22.9% Annualized Using Options
March 23, 2018 at 11:55 AM EDT
Investors considering a purchase of Merrimack Pharmaceuticals Inc (MACK) shares, but tentative about paying the going market price of $8.84/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the September put at the $7 strike, which has a bid at the time of this writing of 80 cents..